Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.3200
-0.0167 (-4.96%)
At close: Aug 17, 2026, 4:00 PM EDT
0.3199
-0.0001 (-0.03%)
Pre-market: Aug 18, 2026, 6:39 AM EDT
Heron Therapeutics Stock Forecast
HRTX's stock price has decreased by -75.94% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Heron Therapeutics stock have an average target of $2.00, which predicts a 525.00% increase from the current stock price of 0.32.
Price Target: $2.00 (+525.00%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Heron Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Aug 18, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 10, 2026 |
Financial Forecast
Revenue This Year
148.25M
from 154.90M
Decreased by -4.30%
Revenue Next Year
145.90M
from 148.25M
Decreased by -1.59%
EPS This Year
-0.13
from -0.05
EPS Next Year
-0.11
from -0.13
EPS and Forward PE are based on non-GAAP adjusted numbers.